Skip to search formSkip to main contentSkip to account menu

cinacalcet hydrochloride

Known as: Hydrochloride, Cinacalcet, 1-Naphthalenemethanamine, a-methyl-N-(3-(3-(trifluoromethyl)phenyl)propyl)-,(aR)-, Hydrochloride, Alpha-methyl-N-(3-(3-(trifluoromethyl)phenyl)propyl)-1-naphthalenemethanamine, (alphaR)-hydrochloride 
The orally bioavailable hydrochloride salt of the calcimimetic cinacalcet. Cinacalcet increases the sensitivity of calcium-sensing receptors on chief… 
National Institutes of Health

Related topics

Related topics

12 relations

Narrower (1)

AMG 073

Broader (1)

Calcimimetic Agents
In BloodNCIt Antineoplastic Agent Terminologyagonistsanalogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Managing hyperparathyroidism in hemodialysis: role of etelcalcetide
Secondary hyperparathyroidism (SHPT) is common in patients receiving maintenance hemodialysis and is associated with adverse… 
Review
2015
Review
2015
Molecular and Clinical Aspects of the Target Therapy with the Calcimimetic Cinacalcet in the Treatment of Parathyroid Tumors.
Parathyroid tumors are almost invariably associated with parathormone (PTH) hypersecretion resulting in primary (PHPT) or… 
2013
2013
Cinacalcet Upregulates Calcium-Sensing Receptors of Parathyroid Glands in Hemodialysis Patients
Background: Cinacalcet hydrochloride (cinacalcet), a calcimimetic, has been shown to upregulate calcium-sensing receptor (CaSR… 
2011
2011
Tertiary Hyperparathyroidism Resistant to Cinacalcet Treatment
Cinacalcet hydrochloride (cinacalcet) has been reported to be efficacious for patients with tertiary hyperparathyroidism (THPT… 
2011
2011
Effective use of cinacalcet for the treatment of secondary hyperparathyroidism in Austrian dialysis patients – Results of the Austrian cohort of the ECHO study
ZusammenfassungHINTERGRUND: Trotz extensiven Einsatzes der vorhandenen Standardtherapeutika befindet sich der Großteil der… 
2009
2009
Evolution of secondary hyperparathyroidism after kidney transplantation in patients receiving cinacalcet on dialysis.
2008
2008
Impact of Cinacalcet Hydrochloride on the Achievement of the Japanese Society for Dialysis Therapy (JSDT) Guideline Targets: A post‐hoc Analysis of the KRN1493 Study
The Japanese Society for Dialysis Therapy (JSDT) released the Guidelines for the Management of Secondary Hyperparathyroidism in… 
2008
2008
Change in Coronary Artery Calcification Score due to Cinacalcet Hydrochloride Administration
We examined the influence of cinacalcet on vascular calcification by measuring the coronary artery calcification score (CACS) in… 
Review
2008
Review
2008
Cinacalcet should not be used to treat secondary hyperparathyroidism in stage 3–4 chronic kidney disease
In the first of two opposing Viewpoints, Daniel W Coyne questions the use of cinacalcet to treat secondary hyperparathyroidism in… 
2002
2002
Cinacalcet hydrochloride: Treatment of hyperparathyroidism
Hyperparathyroidism is characterized by high levels of circulating calcium due to an increased secretion of parathyroid hormone… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)